اثر تمرین بازتوانی قلبی به دو شکل تداومی و تناوبی بر فاکتور نکروز توموری آلفا (TNF-α)، اینترلوکین 1 بتا (IL-1β) و اینترلوکین 6 (IL-6) سرمی در بیماران پیوند عروق کرونر

نوع مقاله : مقاله های پژوهشی

نویسندگان

1 گروه فیزیولوژی ورزشی، دانشکده‌ی تربیت بدنی و علوم ورزشی، دانشگاه الزهرا (س)، تهران، ایران

2 متخصص بیماری‌های قلبی- عروقی، گروه قلب و عروق، دانشکده‌ی پزشکی و بیمارستان امیر کبیر اراک، دانشگاه علوم پزشکی اراک، ایران

3 دانشجوی دکتری فیزیولوژی قلب و عروق و تنفس، گروه فیزیولوژی ورزش، دانشکده‌ی تربیت بدنی و علوم ورزشی، دانشگاه تربیت دبیر شهید رجایی، تهران، ایران

چکیده

مقدمه: پژوهش حاضر با هدف بررسی اثر تمرین بازتوانی قلبی به دو شکل تداومی و تناوبی بر بر فاکتور نکروز توموری آلفا (Tumor necrosis factor-alpha یا TNF-α)، اینترلوکین 1 بتا (Interleukin 1 beta یا IL-1β) و اینترلوکین 6 (Interleukin 6 یا IL-6) سرمی در بیماران پیوند عروق کرونر بود.روش‌ها: تعداد 30 نفر از بیمارانی که حدود یک ماه از عمل جراحی آن‌ها گذشته بود، به صورت مساوی و تصادفی به سه گروه تمرین تناوبی، تمرین تدوامی و شاهد تقسیم شدند. افراد با توجه به گروهی که داشتند، در برنامه‌ی تناوبی شدید (در هر جلسه دو زمان 10 دقیقه‌ای شامل 15ثانیه فعالیت با 100 درصد برون‌ده اوج توان، 15 ثانیه استراحت غیر فعال و 4 دقیقه استراحت بین دو نوبت 10 دقیقه‌ای) و یا تداومی (25-20 دقیقه تمرین طولانی با شدت متوسط) به مدت 8 هفته تمرین نمودند. برای گروه شاهد، هیچ گونه تمرین بازتوانی انجام نشد و پس از اتمام مطالعه، همان تمرین‌ها برای این گروه اعمال گردید. نمونه‌های خونی به منظور ارزیابی IL-6، TNF-α و IL-1β جمع‌آوری شد. برای تجزیه و تحلیل داده‌ها، از آزمون Repeated measures ANOVA و از آزمون تعقیبی Bonferroni جهت تعیین محل تفاوت استفاده شد. کلیه‌ی تحلیل‌های آماری در سطح 050/0 > P انجام گردید.یافته‌ها: سطح TNF-α و IL-1β سرم پس از 8 هفته تمرین بازتوانی در گروه‌های مداخله به طور معنی‌داری کاهش یافت. همچنین، مقایسه‌ی بین گروهی اختلاف معنی‌داری را بین تغییرات TNF-α و IL-1β در دو گروه مداخله نشان داد که این کاهش در گروه تمرین تناوبی بیش از تمرین تداومی بود (050/0 > P). اجرای تمرینات تداومی و تناوبی باعث تغییر معنی‌دار در سطح IL-6 در بیماران پیوند عروق کرونر نشد (050/0 < P).نتیجه‌گیری: با انجام تمرینات ورزشی به خصوص تمرین تناوبی، شاخص‌های پیش‌التهابی کاهش می‌یابد و از عوارض مجدد بعد از عمل نظیر گرفتگی مجدد عروق پیش‌گیری می‌شود.

کلیدواژه‌ها


عنوان مقاله [English]

The Effect of Continuous and Interval Cardiac Rehabilitation Exercise Training on Tumor Necrosis Factor-Alpha (TNF-α), Interleukin 1 Beta (IL-1β), and Interleukin 6 (IL-6) in Patients with Coronary Artery Bypass Graft

نویسندگان [English]

  • Negin Kordi 1
  • Neda Shafiee 1
  • Saeedeh Mirzaei 1
  • khosro Minavand 2
  • Naser Heidari 3
1 Department of Sport Physiology, School of Physical Education and Sport Sciences, Alzahra University, Tehran, Iran
2 Cardiologist, Department of Cardiology, School of Medicine AND Amirkabir Hospital, Arak University of Medical Sciences, Arak, Iran
3 PhD Student of Cardiorespiratory Physiology, Department of Sport Physiology, School of Physical Education and Sport Sciences, Shahid Rajaee Teaching Training University, Tehran, Iran
چکیده [English]

Background: This study aimed to investigate the effect of continuous and interval cardiac rehabilitation exercise training on tumor necrosis factor-alpha (TNF-α), interleukin 1 beta (IL-1β), and interleukin 6 (IL-6) in patients with coronary artery bypass graft (CABG).Methods: 30 patients with coronary artery bypass graft surgery up to one month ago were randomly selected and assigned to control, and interval and continuous exercise training groups (n = 10 for each one). Subjects performed their special exercise training program for eight weeks based on their groups, interval exercise training: 15 seconds of high-intensity training and 15 seconds of rest, and continuous exercise training: 20-25 minutes of moderate-intensity training. Blood samples were collected to evaluate IL-6, TNF-α, and IL-1β. Repeated measure ANOVA was used to show the difference and Bonferron's post hoc test to determine the location of the difference. All statistical analysis were done at the significant level of P < 0.05.Findings: Serum levels of TNF-α and IL-1β decreased significantly after 8 weeks of rehabilitation exercise training in two experimental group. Moreover, a significant difference was seen between exercise training groups, as interval exercise training induced more decline in TNF-α and IL-1β decline compared to continuation exercise training (P < 0.050). Two type of rehabilitation exercise training did not significantly change the level of IL-6 in patients with coronary artery bypass graft (P > 0.050).Conclusion: By performing exercise training, especially interval exercise training, the pre-inflammatory indexes reduce, and it prevents postoperative complications such as revascularization and stroke.

کلیدواژه‌ها [English]

  • Coronary Artery Bypass Grafting
  • Rehabilitation exercise
  • Inflammation
  1. Hammett CJ, Oxenham HC, Baldi JC, Doughty RN, Ameratunga R, French JK, et al. Effect of six months' exercise training on C-reactive protein levels in healthy elderly subjects. J Am Coll Cardiol 2004; 44(12): 2411-3.
  2. Mathur N, Pedersen BK. Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm 2008; 2008: 109502.
  3. Kohut ML, McCann DA, Russell DW, Konopka DN, Cunnick JE, Franke WD, et al. Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults. Brain Behav Immun 2006; 20(3): 201-9.
  4. Pedersen M, Bruunsgaard H, Weis N, Hendel HW, Andreassen BU, Eldrup E, et al. Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev 2003; 124(4): 495-502.
  5. Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic inflammation. Clin Chim Acta 2010; 411(11-12): 785-93.
  6. Sousa N, Mendes R, Abrantes C, Sampaio J, Oliveira J. A randomized 9-month study of blood pressure and body fat responses to aerobic training versus combined aerobic and resistance training in older men. Exp Gerontol 2013; 48(8): 727-33.
  7. Christiansen T, Paulsen SK, Bruun JM, Pedersen SB, Richelsen B. Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: A 12-week randomized intervention study. Am J Physiol Endocrinol Metab 2010; 298(4): E824-E831.
  8. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Martin BS, et al. Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: A randomized controlled trial. Brain Behav Immun 2005; 19(5): 381-8.
  9. Arsenault BJ, Cote M, Cartier A, Lemieux I, Despres JP, Ross R, et al. Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressure. Atherosclerosis 2009; 207(2): 530-3.
  10. Welsh P, Woodward M, Rumley A, Lowe G. Associations of circulating TNFalpha and IL-18 with myocardial infarction and cardiovascular risk markers: the Glasgow Myocardial Infarction Study. Cytokine 2009; 47(2): 143-7.
  11. Ogawa K, Sanada K, Machida S, Okutsu M, Suzuki K. Resistance exercise training-induced muscle hypertrophy was associated with reduction of inflammatory markers in elderly women. Mediators Inflamm 2010; 2010: 171023.
  12. Luo JG. Relationship between serum IL-8 hsCRP, TNF-alpha and coronary lesions in CHD patients. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2010; 26(8): 789-91. [In Chinese].
  13. Conraads VM, Beckers P, Bosmans J, De Clerck LS, Stevens WJ, Vrints CJ, et al. Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease. Eur Heart J 2002; 23(23): 1854-60.
  14. Gielen S, Adams V, Mobius-Winkler S, Linke A, Erbs S, Yu J, et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 2003; 42(5): 861-8.
  15. Larsen AI, Aukrust P, Aarsland T, Dickstein K. Effect of aerobic exercise training on plasma levels of tumor necrosis factor alpha in patients with heart failure. Am J Cardiol 2001; 88(7): 805-8.
  16. Mattusch F, Dufaux B, Heine O, Mertens I, Rost R. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 2000; 21(1): 21-4.
  17. Chaikate S, Harnroongroj T, Chantaranipapong Y, Puduang S, Mahaisiriyodom A, Viroonudomphol D, et al. C-reactive protein, interleukin-6, and tumor necrosis factor-alpha levels in overweight and healthy adults. Southeast Asian J Trop Med Public Health 2006; 37(2): 374-81.
  18. Csiszar A, Ungvari Z. Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease. Med Hypotheses 2004; 63(4): 696-8.
  19. Hashmi S, Zeng QT. Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron Artery Dis 2006; 17(8): 699-706.
  20. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105(7): 804-9.
  21. Scott JP, Sale C, Greeves JP, Casey A, Dutton J, Fraser WD. Effect of exercise intensity on the cytokine response to an acute bout of running. Med Sci Sports Exerc 2011; 43(12): 2297-306.
  22. Cupps TR, Fauci AS. Corticosteroid-mediated immunoregulation in man. Immunol Rev 1982; 65: 133-55.
  23. Kadoglou NP, Iliadis F, Sailer N, Athanasiadou Z, Vitta I, Kapelouzou A, et al. Exercise training ameliorates the effects of rosiglitazone on traditional and novel cardiovascular risk factors in patients with type 2 diabetes mellitus. Metabolism 2010; 59(4): 599-607.
  24. Hasdai D, Scheinowitz M, Leibovitz E, Sclarovsky S, Eldar M, Barak V. Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. Heart 1996; 76(1): 24-8.
  25. Pinto A, Di Raimondo D, Tuttolomondo A, Butta C, Milio G, Licata G. Effects of physical exercise on inflammatory markers of atherosclerosis. Curr Pharm Des 2012; 18(28): 4326-49.